Abstract
Natural products have been identified as ligands for a number of members of the nuclear hormone receptor (NHR) superfamily. Often these natural products are used as dietary supplements to treat myriad ailments ranging from perimenopausal hot flashes to hypercholesterolemia and reduced cognitive function. Examples of some natural product ligands for NHRs include genestein (estrogen receptors NR3A1 and NR3A2), guggulsterone (farnesoid X receptor NR1H4), and St. John's wort (pregnane X receptor, NR1I2). In this study, we identified the first nonoxysterol natural product that functions as a ligand for the liver X receptor (LXRα and LXRβ; NR1H3, NR1H2), a NHR that acts as the receptor for oxysterols and plays a key role in regulation of cholesterol metabolism and transport as well as glucose metabolism. We show that paxilline, a fungal metabolite, is an efficacious agonist of both LXRα and LXRβ in biochemical and in vitro cell-based assays. Paxilline binds directly to both receptors and is an activator of LXR-dependent transcription in cell-based reporter assays. We also demonstrate that paxilline binding to the receptors results in efficient activation of transcription of two physiological LXR target genes, ABCA1 and SREBP. The discovery of paxilline, the first reported nonoxysterol natural product ligand of the LXRs, may provide insight into the mechanism of ligand recognition by these receptors and reaffirms the utility of examining natural product libraries for identifying novel NHR ligands.
Footnotes
-
ABBREVIATIONS: PXR, pregnane X receptor; LXR, liver X receptor; FXR, farnesoid X receptor; LBD, ligand binding domain; SRC-1, steroid receptor coactivator-1; TIF-2, transcription intermediary factor-2; GST, glutathione S-transferase; OHC, hydroxycholesterol; ER, estrogen receptor; bDNA, branched DNA; RXR, retinoid X receptor; DMEM, Dulbecco's modified Eagle's medium; SRE, sterol regulatory element; SREBP, SRE binding protein; 22(R)-OHC, 22(R)-hydroxycholesterol.
-
DOI: 10.1124/jpet.103.052852.
- Received April 8, 2003.
- Accepted June 12, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|